시장보고서

상품코드

1927683

CRISPR 기반 POC 진단 시장 : 제품 유형별, 기술 유형별, 탐지 방법별, 용도별, 국가별, 지역별 - 산업 분석, 시장 규모, 점유율, 예측(2025-2032년)

CRISPR-based POC Diagnostics Market, By Product Type, By Technology Type, By Detection Method, By Application, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

발행일: 2026년 01월 | 리서치사:

AnalystView Market Insights | 페이지 정보: 영문 367 Pages | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

CRISPR 기반 POC 진단 시장 규모는 2024년에 5억 512만 달러로 평가되며, 2025-2032년에 CAGR 15.85%로 확대하고 있습니다.

CRISPR POC(Point-of-Care) 진단은 CRISPR 유전자 편집 효소를 활용하여 병원체를 매우 특이적이고 민감하게 검출하는 신속 분자 검사 솔루션입니다. 감염병 관리, 특히 호흡기 질환 및 신종 감염병에 대한 분산형 및 신속 진단에 대한 수요 증가가 시장 성장을 주도하고 있습니다. 저자원 및 원격의료 환경에서 사용하기에 필수적인 짧은 처리 시간을 실현하는 다중화 및 장비가 필요 없는 분석법 개발이 기회로 작용할 수 있습니다. 눈에 띄는 동향으로는 정확도 향상과 편의성 개선을 목적으로 마이크로플루이딕스 기술 및 휴대용 리더기와의 통합이 진행되고 있습니다. 그러나 규제의 복잡성, 제조의 확장성, 장기적인 임상 검증의 부족 등의 문제로 인해 일상적인 진단 및 대규모 스크리닝 프로그램에서의 보급을 가로막고 있습니다.

CRISPR 기반 POC 진단 시장 역학

의료 현장 전반의 신속한 분산형 진단 검사 도입 확대

병원, 진료소, 원격의료 환경에서 신속하고 분산된 진단 검사가 채택되는 사례가 증가하면서 CRISPR POC(Point-of-Care) 진단에 대한 수요가 크게 증가하고 있습니다. 이러한 진단 기술은 질병을 적시에 정확하게 감지할 수 있도록 하는 데 중요한 역할을 하고 있습니다. 의료 시스템이 조기 진단, 발병 통제, 개인별 맞춤 치료에 더 중점을 두면서 의료 서비스 프로바이더는 센트럴 랩 밖에서도 도입할 수 있는 고감도, 고특이성 검사 솔루션을 필요로 하고 있습니다. CRISPR 기반 POC 진단은 환자 현장 또는 그 근처에서 병원체, 유전자 마커, 감염성 병원체를 분자 수준에서 신속하게 검출할 수 있도록 함으로써 이러한 요구에 대응합니다. 응급의료, 감염병 관리, 공중보건 감시에서 신속한 진단 결과에 대한 의존도가 높아지면서 도입이 가속화되고 있습니다. 특히 1차 진료 및 자원이 제한된 환경에서 휴대성이 높고 사용하기 쉬운 진단 툴에 대한 수요로 인해 제조업체들은 정확성을 떨어뜨리지 않으면서도 작고 장비 의존도가 낮은 CRISPR 플랫폼의 개발을 추진하고 있습니다. 또한 감염병 발생 빈도가 증가함에 따라 확장성과 분산형 검사 솔루션의 중요성이 부각되면서 시장 성장을 촉진하고 있습니다. 예를 들어 최근 세계 보건 위기에서 신속 분자 검사의 활용 확대는 진단 지연을 줄이는 데 있으며, 현장진단(POC) 진단의 가치를 입증했습니다. 또한 스크리닝, 모니터링 및 재택 치료에서 POC 검사의 보급은 신뢰할 수 있고 신속하며 사용자 친화적인 CRISPR 기반 진단 솔루션의 필요성을 더욱 강화시키고 있습니다.

CRISPR 기반 POC 진단 시장 : 세분화 분석

세계 CRISPR 기반 POC 진단 시장은 제품 유형, 기술 유형, 검출 방법, 애플리케이션, 지역별로 세분화되어 있습니다.

제품 유형에 따른 시장 세분화는 진단 키트, 시약 및 효소, 일회용 카트리지, 분석 패널의 4가지로 분류됩니다. 이 중 진단키트 부문은 임상 현장에서의 직접적인 적용 가능성과 현장 사용의 용이성으로 인해 시장을 주도하고 있습니다. 시약 및 효소 부문은 분석법 개발, 맞춤화, 반복 검사 용도(특히 민감도와 특이성을 결정하는 CRISPR 관련 효소)의 지속적인 수요에 힘입어 2위를 차지했습니다. 일회용 카트리지는 워크플로우 간소화 및 대규모 스크리닝 및 원격의료 환경에서의 확장성, 무공해 일회용 검사 형식에 대한 관심이 높아지면서 그 중요성이 커지고 있습니다. 분석 패널은 단일 검사로 여러 병원체 및 바이오마커의 다중 검출에 대한 수요가 증가함에 따라 채택이 확대되고 있지만, 개발의 복잡성과 높은 규제 요건으로 인해 현재 보급이 제한되고 있습니다. 이러한 부문은 종합적으로 통합성, 확장성, 신속성을 갖춘 CRISPR 기반 POC 진단 솔루션으로의 전환을 반영하고 있습니다.

시장은 기술 유형에 따라 CRISPR-Cas9, CRISPR-Cas9, CRISPR-Cas12, CRISPR-Cas13, 멀티플렉스 CRISPR 시스템 등 4개 부문으로 나뉩니다. CRISPR-Cas12 부문은 우수한 민감도와 신속한 분산형 진단 용도에 대한 적합성을 바탕으로 시장을 선도하고 있습니다. CRISPR-Cas13은 RNA 표적화 능력에 힘입어 임상적 연관성이 높은 RNA 바이러스 및 감염성 질환의 검출에 특히 적합하다는 점에서 2위를 차지합니다. 멀티플렉스 CRISPR 시스템은 단일 검사로 여러 병원체 또는 유전자 표적의 동시 검출에 대한 수요가 증가함에 따라 보급이 확대되고 있지만, 현재 분석의 복잡성과 최적화 문제로 인해 도입이 지연되고 있습니다. CRISPR-Cas9는 진단보다는 유전자 편집에 널리 사용되고 있으며, 신호 증폭 기능이 없어 신속한 POC 응용에 대한 적합성이 제한적이기 때문에 차선책으로 꼽히고 있습니다. 전반적으로 기술의 우선순위는 성능, 속도, 분산형 진단 플랫폼에 대한 통합 용이성 등을 반영합니다.

CRISPR 기반 POC 진단 시장 - 지역별 분석

CRISPR POC(Point-of-Care) 진단 시장은 지역별로 도입 현황과 성장률에 있으며, 현저한 차이를 보이고 있습니다. 북미는 현재 첨단 의료 인프라, 막대한 연구개발 투자, 특히 미국내 생명공학 기업 및 학술연구기관 집중 등의 이점을 바탕으로 세계 시장을 주도하고 있으며, 이는 CRISPR 진단 플랫폼의 상용화를 가속화하고 있습니다.

유럽은 탄탄한 공공 의료 자금, 독일, 영국, 프랑스 등 여러 국가의 공동 연구 생태계, 그리고 임상 워크플로우에 CRISPR 분석의 통합이 진행되고 있는 것을 배경으로 두 번째 점유율을 차지하고 있습니다.

아시아태평양은 의료비 지출 증가, 생명공학 혁신에 대한 정부 지원, 중국, 인도, 일본, 동남아시아의 급속한 진단법 보급 확대를 배경으로 가장 높은 성장률을 보일 것으로 예측됩니다.

전략적 산업 동향이 각 지역의 모멘텀을 지원하고 있습니다. 예를 들어 인도의 생명공학 기업 CrisprBits는 Molbio Diagnostics와 전략적 제휴를 맺고 POC CRISPR 검사의 개발 및 상용화를 추진하고 있으며, 이를 통해 지역 및 세계 시장에서의 접근성을 높이고 있습니다.

CRISPR 기반 POC 진단 시장 - 국가별 분석

CRISPR 기반 POC 진단 시장의 국가별 동향은 의료 정책의 우선순위, 투자 환경, 혁신 생태계의 차이를 반영하고 있습니다. 미국은 강력한 생명공학 연구개발 자금, 신규 진단기술에 대한 규제 지원, CRISPR 플랫폼의 조기 상용화를 통해 세계를 선도하고 있으며, 임상 현장에서 높은 시장 점유율과 보급을 실현하고 있습니다. 유럽에서는 독일, 영국, 프랑스 등의 국가들이 공동 연구 네트워크와 신속하고 정확한 진단 툴을 추구하는 의료 시스템으로의 통합에 힘입어 미국에 이어 두 번째로 성장세를 보이고 있습니다. 아시아태평양 시장, 특히 중국, 인도, 일본에서는 감염병 부담 증가, 바이오테크놀러지 투자 확대, 의료 인프라 구축이 진행되고 있으며, 시장이 빠르게 확대되고 있으며, 이들 국가는 POC CRISPR의 빠른 도입이 기대되고 있습니다.

전략적 동향으로는 미국 오라슈어 테크놀러지스(OraSure Technologies)의 Sherlock Biosciences 인수로 CRISPR 진단 제품 확장을 꾀하고 있습니다. 또한 인도의 CrisprBits社와 Molbio Diagnostics社와 전략적 제휴를 통해 국내 및 국제 시장을 대상으로 POC CRISPR 검사의 공동 개발 및 보급을 추진하고 있습니다.

서론
북미
- 개요
- 북미의 주요 제조업체
- 미국
- 캐나다
유럽
- 개요
- 유럽의 주요 제조업체
- 독일
- 영국
- 프랑스
- 이탈리아
- 스페인
- 네덜란드
- 스웨덴
- 러시아
- 폴란드
- 기타
아시아태평양(APAC)
- 개요
- 아시아태평양의 주요 제조업체
- 중국
- 인도
- 일본
- 한국
- 호주
- 인도네시아
- 태국
- 필리핀
- 기타
라틴아메리카(LATAM)
- 개요
- 라틴아메리카의 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
중동 및 아프리카(MEA)
- 개요
- 중동 및 아프리카의 주요 제조업체
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 튀르키예
- 알제리
- 이집트
- 기타

제12장 주요 벤더 분석 : CRISPR 기반 POC 진단 업계

경쟁 대시보드
- 경쟁 벤치마킹
- 경쟁 포지셔닝
기업 개요
- Abbott Laboratories
- Agilent Technologies
- AstraZeneca
- Becton, Dickinson and Company
- Bio-Rad Laboratories
- Caspr Biotech
- Danaher Corporation
- Detect Inc.
- Hologic
- Illumina
- Lucira Health
- Mammoth Biosciences
- Merck KGaA
- Qiagen
- QuidelOrtho
- Roche Diagnostics
- Sherlock Biosciences
- Siemens Healthineers
- Thermo Fisher Scientific
- Twist Bioscience
- Others

제13장 AnalystView의 전방위적 분석

KSA 26.02.25

CRISPR-based POC Diagnostics Market size was valued at US$ 505.12 Million in 2024, expanding at a CAGR of 15.85% from 2025 to 2032.

CRISPR-based point-of-care (POC) diagnostics are rapid molecular testing solutions that leverage CRISPR gene-editing enzymes for highly specific and sensitive detection of pathogens. Rising demand for decentralized, fast diagnostics in infectious disease management, particularly for respiratory and emerging diseases, is driving market growth. Opportunities lie in developing multiplexed and instrument-free assays with shorter turnaround times, essential for use in low-resource and remote healthcare settings. A prominent trend is the integration of CRISPR diagnostics with microfluidics and portable readers to enhance accuracy while improving usability. However, challenges such as regulatory complexity, scalability of manufacturing, and limited long-term clinical validation restrain widespread adoption in routine diagnostics and large-scale screening programs.

CRISPR-based POC Diagnostics Market- Market Dynamics

Increasing adoption of rapid, decentralized diagnostic testing across healthcare settings

The increasing adoption of rapid, decentralized diagnostic testing across hospitals, clinics, and remote healthcare settings is significantly driving demand for CRISPR-based point-of-care (POC) diagnostics, which play a critical role in enabling timely and accurate disease detection. As healthcare systems place greater emphasis on early diagnosis, outbreak control, and personalized treatment, providers require highly sensitive and specific testing solutions that can be deployed outside centralized laboratories. CRISPR-based POC diagnostics address this need by enabling rapid molecular detection of pathogens, genetic markers, and infectious agents at or near the patient site. The growing reliance on fast-turnaround diagnostics in emergency care, infectious disease management, and public health surveillance is accelerating adoption. In particular, the demand for portable and easy-to-use diagnostic tools in primary care and low-resource settings is pushing manufacturers to develop compact, instrument-light CRISPR platforms without compromising accuracy. Moreover, the rising frequency of infectious disease outbreaks has highlighted the importance of scalable and decentralized testing solutions, further supporting market growth. For instance, increased use of rapid molecular tests during recent global health emergencies demonstrated the value of point-of-care diagnostics in reducing diagnostic delays. Additionally, the expanding use of POC testing in screening, surveillance, and home-based care is reinforcing the need for reliable, fast, and user-friendly CRISPR-based diagnostic solutions.

CRISPR-based POC Diagnostics Market- Segmentation Analysis:

The Global CRISPR-based POC Diagnostics Market is segmented on the basis of Product Type, Technology Type, Detection Method, Application, and Region.

The market is segmented into four categories based on product type: diagnostic kits, reagents & enzymes, disposable cartridges, and assay panels. Among these, the diagnostic kits segment dominates the market due to its direct clinical applicability and ease of use in point-of-care settings. Reagents & Enzymes rank second, driven by continuous demand from assay development, customization, and repeated test usage, particularly CRISPR-associated enzymes that determine sensitivity and specificity. Disposable Cartridges follow, gaining importance due to rising emphasis on contamination-free, single-use testing formats that simplify workflows and support scalability in mass screening and remote healthcare environments. Assay Panels rank next, as their adoption is growing with demand for multiplex detection of multiple pathogens or biomarkers in a single test, though higher development complexity and regulatory requirements currently limit widespread uptake. Collectively, these segments reflect a shift toward integrated, scalable, and rapid CRISPR-based POC diagnostic solutions.

The market is categorized into four segments based on technology type: CRISPR-Cas9, CRISPR-Cas12, CRISPR-Cas13, and multiplex CRISPR systems. The CRISPR-Cas12 segment leads the market, driven by its superior sensitivity and suitability for rapid, decentralized diagnostic applications. CRISPR-Cas13 ranks second, driven by its RNA-targeting capability, making it particularly suitable for detecting RNA viruses and infectious diseases with high clinical relevance. Multiplex CRISPR Systems follow, gaining traction as demand increases for simultaneous detection of multiple pathogens or genetic targets in a single test, although assay complexity and optimization challenges currently moderate adoption. CRISPR-Cas9 ranks next, as it is more widely used in gene editing than diagnostics and lacks inherent signal amplification features, limiting its suitability for rapid POC applications. Overall, technological prioritization reflects performance, speed, and ease of integration into decentralized diagnostic platforms.

CRISPR-based POC Diagnostics Market- Geographical Insights

The CRISPR-based point-of-care (POC) diagnostics market exhibits significant regional variation in adoption and growth rates. North America currently dominates the global landscape, benefiting from advanced healthcare infrastructure, substantial R&D investment, and a strong concentration of biotechnology companies and academic research institutions, particularly in the United States, which accelerates the commercialization of CRISPR diagnostic platforms.

Europe holds the second-largest share, supported by robust public health funding, collaborative research ecosystems in countries such as Germany, the UK, and France, and increasing integration of CRISPR assays into clinical workflows.

The Asia-Pacific region is projected to experience the fastest growth rate, driven by rising healthcare expenditure, government support for biotechnology innovation, and expanding use of rapid diagnostics across China, India, Japan, and Southeast Asia.

Strategic industry developments underscore regional momentum. For instance, Indian biotech firm CrisprBits entered a strategic collaboration with Molbio Diagnostics to develop and commercialize POC CRISPR tests, enhancing accessibility in local and global markets.

CRISPR-based POC Diagnostics Market- Country Insights

Country-level dynamics in the CRISPR-based point-of-care (POC) diagnostics market reflect differing healthcare priorities, investment climates, and innovation ecosystems. The United States leads globally, driven by strong biotech R&D funding, regulatory support for novel diagnostics, and early commercialization of CRISPR platforms, resulting in significant market share and adoption in clinical settings. Europe, with countries such as Germany, the United Kingdom, and France, follows closely, supported by collaborative research networks and integration into healthcare systems seeking rapid, accurate diagnostic tools. Asia-Pacific markets, notably China, India, and Japan, are fast expanding due to rising infectious disease burdens, increased biotech investment, and growing healthcare infrastructure, positioning these nations for rapid POC CRISPR adoption.

Strategic developments include the acquisition of Sherlock Biosciences by OraSure Technologies in the US to broaden CRISPR diagnostic offerings, and a strategic collaboration between India's CrisprBits and Molbio Diagnostics to co-develop and deploy POC CRISPR tests domestically and internationally.

CRISPR-based POC Diagnostics Market- Competitive Landscape:

The competitive landscape of the CRISPR-based point-of-care (POC) diagnostics market is characterized by rapid innovation, strategic partnerships, and consolidation among key biotechnology and diagnostics firms. Leading players such as Mammoth Biosciences, OraSure Technologies (via Sherlock Biosciences), Caspr Biotech, Integrated DNA Technologies (IDT), and GenScript are actively developing and commercializing CRISPR-based diagnostic platforms that combine high sensitivity with decentralized usability. Competitive differentiation is achieved through assay performance, patent portfolios, and integration with portable devices. Market activity includes acquisitions that strengthen technological capabilities and accelerate time-to-market; notably, Sherlock Biosciences acquired Sense Bio detection to integrate instrument-free molecular test hardware with its CRISPR technology, broadening its point-of-care portfolio.

Collaborations also enhance competitiveness, such as strategic alliances between CrisprBits and Molbio Diagnostics to co-develop and distribute rapid POC tests, expanding market reach and accelerating adoption in diverse healthcare settings.

Recent Developments:

In August 2023, CrisprBits entered a strategic collaboration with Molbio Diagnostics to jointly develop and launch CRISPR-based point-of-care (POC) tests, combining CrisprBits' PathCrisp platform with Molbio's manufacturing and distribution network to deliver rapid, affordable diagnostics globally.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CRISPR-BASED POC DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Abbott Laboratories
Agilent Technologies
AstraZeneca
Becton, Dickinson and Company
Bio-Rad Laboratories
Caspr Biotech
Danaher Corporation
Detect Inc.
Hologic
Illumina
Lucira Health
Mammoth Biosciences
Merck KGaA
Qiagen
QuidelOrtho
Roche Diagnostics
Sherlock Biosciences
Siemens Healthineers
Thermo Fisher Scientific
Twist Bioscience
Others

GLOBAL CRISPR-BASED POC DIAGNOSTICS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

Diagnostic Kits
Reagents & Enzymes
Disposable Cartridges
Assay Panels

GLOBAL CRISPR-BASED POC DIAGNOSTICS MARKET, BY TECHNOLOGY TYPE- MARKET ANALYSIS, 2019 - 2032

CRISPR-Cas9
CRISPR-Cas12
CRISPR-Cas13
Multiplex CRISPR Systems

GLOBAL CRISPR-BASED POC DIAGNOSTICS MARKET, BY DETECTION METHOD- MARKET ANALYSIS, 2019 - 2032

Fluorescence-Based Detection
Colorimetric Detection
Electrochemical Detection
Lateral Flow Readout

GLOBAL CRISPR-BASED POC DIAGNOSTICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

Infectious Disease Detection
Genetic Disorder Screening
Oncology Diagnostics
Antimicrobial Resistance Testing

GLOBAL CRISPR-BASED POC DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. CRISPR-based POC Diagnostics Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. CRISPR-based POC Diagnostics Market Snippet by Product Type
- 2.1.2. CRISPR-based POC Diagnostics Market Snippet by Technology Type
- 2.1.3. CRISPR-based POC Diagnostics Market Snippet by Detection Method
- 2.1.4. CRISPR-based POC Diagnostics Market Snippet by Application
- 2.1.5. CRISPR-based POC Diagnostics Market Snippet by Country
- 2.1.6. CRISPR-based POC Diagnostics Market Snippet by Region
2.2. Competitive Insights

3. CRISPR-based POC Diagnostics Key Market Trends

3.1. CRISPR-based POC Diagnostics Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. CRISPR-based POC Diagnostics Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. CRISPR-based POC Diagnostics Market Opportunities
3.4. CRISPR-based POC Diagnostics Market Future Trends

4. CRISPR-based POC Diagnostics Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. CRISPR-based POC Diagnostics Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. CRISPR-based POC Diagnostics Market Landscape

6.1. CRISPR-based POC Diagnostics Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. CRISPR-based POC Diagnostics Market - By Product Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
- 7.1.2. Diagnostic Kits
- 7.1.3. Reagents & Enzymes
- 7.1.4. Disposable Cartridges
- 7.1.5. Assay Panels

8. CRISPR-based POC Diagnostics Market - By Technology Type

8.1. Overview
- 8.1.1. Segment Share Analysis, By Technology Type, 2024 & 2032 (%)
- 8.1.2. CRISPR-Cas9
- 8.1.3. CRISPR-Cas12
- 8.1.4. CRISPR-Cas13
- 8.1.5. Multiplex CRISPR Systems

9. CRISPR-based POC Diagnostics Market - By Detection Method

9.1. Overview
- 9.1.1. Segment Share Analysis, By Detection Method, 2024 & 2032 (%)
- 9.1.2. Fluorescence-Based Detection
- 9.1.3. Colorimetric Detection
- 9.1.4. Electrochemical Detection
- 9.1.5. Lateral Flow Readout

10. CRISPR-based POC Diagnostics Market - By Application

10.1. Overview
- 10.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
- 10.1.2. Infectious Disease Detection
- 10.1.3. Genetic Disorder Screening
- 10.1.4. Oncology Diagnostics
- 10.1.5. Antimicrobial Resistance Testing

11. CRISPR-based POC Diagnostics Market- By Geography

11.1. Introduction
- 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
11.2. North America
- 11.2.1. Overview
- 11.2.2. CRISPR-based POC Diagnostics Key Manufacturers in North America
- 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.2.5. North America Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
- 11.2.6. North America Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
- 11.2.7. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.2.8. U.S.
  - 11.2.8.1. Overview
  - 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.2.8.4. U.S. Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.2.8.5. U.S. Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.2.8.6. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.2.9. Canada
  - 11.2.9.1. Overview
  - 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.2.9.4. Canada Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.2.9.5. Canada Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.2.9.6. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3. Europe
- 11.3.1. Overview
- 11.3.2. CRISPR-based POC Diagnostics Key Manufacturers in Europe
- 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.5. Europe Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
- 11.3.6. Europe Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
- 11.3.7. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.8. Germany
  - 11.3.8.1. Overview
  - 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.8.4. Germany Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.3.8.5. Germany Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.3.8.6. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.9. UK
  - 11.3.9.1. Overview
  - 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.9.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.9.4. UK Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.3.9.5. UK Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.3.9.6. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.10. France
  - 11.3.10.1. Overview
  - 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.10.4. France Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.3.10.5. France Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.3.10.6. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.11. Italy
  - 11.3.11.1. Overview
  - 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.11.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.11.4. Italy Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.3.11.5. Italy Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.3.11.6. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.12. Spain
  - 11.3.12.1. Overview
  - 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.12.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.12.4. Spain Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.3.12.5. Spain Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.3.12.6. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.13. The Netherlands
  - 11.3.13.1. Overview
  - 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.13.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.13.4. The Netherlands Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.3.13.5. The Netherlands Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.3.13.6. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.14. Sweden
  - 11.3.14.1. Overview
  - 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.14.4. Sweden Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.3.14.5. Sweden Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.3.14.6. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.15. Russia
  - 11.3.15.1. Overview
  - 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.15.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.15.4. Russia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.3.15.5. Russia Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.3.15.6. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.16. Poland
  - 11.3.16.1. Overview
  - 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.16.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.16.4. Poland Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.3.16.5. Poland Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.3.16.6. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.17. Rest of Europe
  - 11.3.17.1. Overview
  - 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.17.4. Rest of the Europe Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.3.17.5. Rest of the Europe Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.3.17.6. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
- 11.4.1. Overview
- 11.4.2. CRISPR-based POC Diagnostics Key Manufacturers in Asia Pacific
- 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.5. APAC Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
- 11.4.6. APAC Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
- 11.4.7. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.8. China
  - 11.4.8.1. Overview
  - 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.8.4. China Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.4.8.5. China Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.4.8.6. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.9. India
  - 11.4.9.1. Overview
  - 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.9.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.9.4. India Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.4.9.5. India Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.4.9.6. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.10. Japan
  - 11.4.10.1. Overview
  - 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.10.4. Japan Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.4.10.5. Japan Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.4.10.6. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.11. South Korea
  - 11.4.11.1. Overview
  - 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.11.4. South Korea Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.4.11.5. South Korea Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.4.11.6. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.12. Australia
  - 11.4.12.1. Overview
  - 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.12.4. Australia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.4.12.5. Australia Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.4.12.6. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.13. Indonesia
  - 11.4.13.1. Overview
  - 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.13.4. Indonesia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.4.13.5. Indonesia Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.4.13.6. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.14. Thailand
  - 11.4.14.1. Overview
  - 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.14.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.14.4. Thailand Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.4.14.5. Thailand Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.4.14.6. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.15. Philippines
  - 11.4.15.1. Overview
  - 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.15.4. Philippines Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.4.15.5. Philippines Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.4.15.6. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.16. Rest of APAC
  - 11.4.16.1. Overview
  - 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.16.4. Rest of APAC Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.4.16.5. Rest of APAC Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.4.16.6. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5. Latin America (LATAM)
- 11.5.1. Overview
- 11.5.2. CRISPR-based POC Diagnostics Key Manufacturers in Latin America
- 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.5.5. LATAM Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
- 11.5.6. LATAM Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
- 11.5.7. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.8. Brazil
  - 11.5.8.1. Overview
  - 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.5.8.4. Brazil Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.5.8.5. Brazil Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.5.8.6. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.9. Mexico
  - 11.5.9.1. Overview
  - 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.5.9.4. Mexico Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.5.9.5. Mexico Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.5.9.6. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.10. Argentina
  - 11.5.10.1. Overview
  - 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.5.10.4. Argentina Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.5.10.5. Argentina Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.5.10.6. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.11. Colombia
  - 11.5.11.1. Overview
  - 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.5.11.4. Colombia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.5.11.5. Colombia Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.5.11.6. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.12. Rest of LATAM
  - 11.5.12.1. Overview
  - 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.5.12.4. Rest of LATAM Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.5.12.5. Rest of LATAM Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.5.12.6. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa (MEA)
- 11.6.1. Overview
- 11.6.2. CRISPR-based POC Diagnostics Key Manufacturers in Middle East and Africa
- 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.6.4. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.6.5. MEA Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
- 11.6.6. MEA Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
- 11.6.7. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.8. Saudi Arabia
  - 11.6.8.1. Overview
  - 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.6.8.4. Saudi Arabia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.6.8.5. Saudi Arabia Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.6.8.6. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.9. United Arab Emirates
  - 11.6.9.1. Overview
  - 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.6.9.4. United Arab Emirates Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.6.9.5. United Arab Emirates Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.6.9.6. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.10. Israel
  - 11.6.10.1. Overview
  - 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.6.10.4. Israel Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.6.10.5. Israel Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.6.10.6. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.11. Turkey
  - 11.6.11.1. Overview
  - 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.6.11.4. Turkey Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.6.11.5. Turkey Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.6.11.6. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.12. Algeria
  - 11.6.12.1. Overview
  - 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.6.12.4. Algeria Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.6.12.5. Algeria Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.6.12.6. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.13. Egypt
  - 11.6.13.1. Overview
  - 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.6.13.4. Egypt Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.6.13.5. Egypt Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.6.13.6. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.14. Rest of MEA
  - 11.6.14.1. Overview
  - 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.6.14.4. Rest of MEA Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.6.14.5. Rest of MEA Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.6.14.6. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- CRISPR-based POC Diagnostics Industry

12.1. Competitive Dashboard
- 12.1.1. Competitive Benchmarking
- 12.1.2. Competitive Positioning
12.2. Company Profiles
- 12.2.1. Abbott Laboratories
- 12.2.2. Agilent Technologies
- 12.2.3. AstraZeneca
- 12.2.4. Becton, Dickinson and Company
- 12.2.5. Bio-Rad Laboratories
- 12.2.6. Caspr Biotech
- 12.2.7. Danaher Corporation
- 12.2.8. Detect Inc.
- 12.2.9. Hologic
- 12.2.10. Illumina
- 12.2.11. Lucira Health
- 12.2.12. Mammoth Biosciences
- 12.2.13. Merck KGaA
- 12.2.14. Qiagen
- 12.2.15. QuidelOrtho
- 12.2.16. Roche Diagnostics
- 12.2.17. Sherlock Biosciences
- 12.2.18. Siemens Healthineers
- 12.2.19. Thermo Fisher Scientific
- 12.2.20. Twist Bioscience
- 12.2.21. Others

13. 360 Degree Analyst View

14. Appendix

14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us